[
    [
        {
            "time": "",
            "original_text": "东吴医药行业周观点：药明康德成为第二家“ IPO快速通道 ”的独角兽公司 创新药主题迎来新一轮投资机会",
            "features": {
                "keywords": [
                    "药明康德",
                    "IPO快速通道",
                    "独角兽公司",
                    "创新药",
                    "投资机会"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "东吴医药行业周观点：药明康德成为第二家“ IPO快速通道 ”的独角兽公司 创新药主题迎来新一轮投资机会",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "[增持评级] 医药生物行业月报：行业发展持续向好 布局有增速、有未来的公司",
            "features": {
                "keywords": [
                    "医药生物",
                    "行业月报",
                    "持续向好",
                    "增速",
                    "未来"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "[增持评级] 医药生物行业月报：行业发展持续向好 布局有增速、有未来的公司",
                "Correlation": 7,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        }
    ]
]